EGFR and head and neck squamous cell carcinoma: Perhaps a more clinically relevant mutation for SCCHN might be the EGFR variant (vIII) mutation, wherein the extracellular ligand binding domain of EGFR contains an in-frame deletion of exons 2–7, rendering EGFR constitutively activated [52].